Table 1 Degradation of endogenous TEAD1, TEAD4 and cIAP1 with IPD hits and negative controls

From: Expanding the toolbox to develop IAP-based degraders of TEAD transcription factors

Compound

Description

NCI-H2052 (TEAD1)

NCI-H2052 (TEAD4)

NCI-H2052 (cIAP1)

NCI-H226 (TEAD1)

DC50 (nM)

Dmax (%)

DC50 (nM)

Dmax (%)

DC50 (nM)

Dmax (%)

DC50 (nM)

Dmax (%)

VT-107

TEAD binder

3

21

-

-

-

-

-

-

A262

TEAD binder

800

36

-

-

-

-

-

-

A341

TEAD binder

2600

38

-

-

-

-

-

-

A232

A230

A231

ALP1 IPD hit

ALP1 IAP neg. control

ALP1 TEAD neg. control

14

970

4100

32

45

40

-

-

-

-

270

240

530

88

36

95

-

-

-

-

-

-

A531

A557

A423

ALP2 IPD hit

ALP2 IAP neg. control

ALP2 TEAD neg. control

170*

140

560

55*

41

23

1100

-

-

33

-

-

20

150

23

94

17

96

77

370

930

53

42

29

A538

A559

A561

XB2 IPD hit

XB2 IAP neg. control

XB2 TEAD neg. control

44#

1500

630

42#

37

10

510

-

-

9

-

-

39

920

360

100

7

97

76

780

1100

38

27

17

  1. Endogenous degradation post 20 h compound treatment (10–0.001 µM) assessed using capillary-based western assay. Data are mean of n = 2 biologically independent experiments except for *(n = 5) and #(n = 3).
  2. - = Not tested.